cladosporin and Diabetes-Mellitus--Type-2

cladosporin has been researched along with Diabetes-Mellitus--Type-2* in 1 studies

Other Studies

1 other study(ies) available for cladosporin and Diabetes-Mellitus--Type-2

Article	Year
Asperentin B, a New Inhibitor of the Protein Tyrosine Phosphatase 1B. Marine drugs, 2017, Jun-21, Volume: 15, Issue:6 In the frame of studies on secondary metabolites produced by fungi from deep-sea environments we have investigated inhibitors of enzymes playing key roles in signaling cascades of biochemical pathways relevant for the treatment of diseases. Here we report on a new inhibitor of the human protein tyrosine phosphatase 1B (PTP1B), a target in the signaling pathway of insulin. A new asperentin analog is produced by an Topics: Aspergillus; Cell Line, Tumor; Diabetes Mellitus, Type 2; Enzyme Inhibitors; HT29 Cells; Humans; Insulin; Isocoumarins; Mediterranean Sea; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Signal Transduction	2017

Article

Year

Asperentin B, a New Inhibitor of the Protein Tyrosine Phosphatase 1B.

Marine drugs, 2017, Jun-21, Volume: 15, Issue:6

In the frame of studies on secondary metabolites produced by fungi from deep-sea environments we have investigated inhibitors of enzymes playing key roles in signaling cascades of biochemical pathways relevant for the treatment of diseases. Here we report on a new inhibitor of the human protein tyrosine phosphatase 1B (PTP1B), a target in the signaling pathway of insulin. A new asperentin analog is produced by an

Topics: Aspergillus; Cell Line, Tumor; Diabetes Mellitus, Type 2; Enzyme Inhibitors; HT29 Cells; Humans; Insulin; Isocoumarins; Mediterranean Sea; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Signal Transduction

2017